An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period.

Publication/Presentation Date

11-1-2019

Volume

12

Issue

11

First Page

13

Last Page

18

ISSN

1941-2789

Disciplines

Medicine and Health Sciences

PubMedID

32038751

Department(s)

Department of Medicine

Document Type

Article

Share

COinS